Publications

RECHERCHE PERSONNELLE : Statistique mathématique, biostatistique & épidémiologie

  • 20) M. Dufournet, E. Lanoy, J-L. Martin, V. Viallon. Recovering causal effects from selection biased data: the case of responsibility analyses in road safety epidemiology. Soumis.
  • 19) V. Viallon, M. Dufournet. Re. Collider bias is only a partial explanation for the obesity paradox. Epidemiology 28(5): e43-e45 (2017).
  • 18) E. Ollier, V. Viallon. Regression modeling on stratified data with the lasso. Biometrika, 104(1): 83-96 (2017).
  • 17) E. Ollier, A. Samson, X. Delavenne, V. Viallon. A SAEM algorithm for fused lasso penalized non-linear mixed effect models: application to group comparison in pharmacokinetics. Computational Statistics and Data Analysis, 95:207-221 (2016).
  • 16) V. Viallon, S. Lambert-Lacroix, H. Höfling, F. Picard. On the robustness of the Generalized Fused Lasso to prior specifications. Statistics and Computing, 26(1):285:301 (2016).
  • 15) J. Coste, F. Tissier, J. Pouchot, E. Ecosse, A. Rouquette, X. Bertagna, R. Libé, V. Viallon. Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer. Cancer Epidemiology; 38(2):200-208 (2014).
  • 14) V. Viallon, O. Banerjee, G. Rey, E. Jougla, J. Coste. An empirical comparative study of approximate methods for binary graphical models; application to the search of associations among causes of death in the French death certificates. Biometrical Journal; 56(2):307-331 (2014).
  • 13) P. Blanche, A. Latouche, V. Viallon. Time-dependent AUC in the presence of censored data: a survey. In Risk Assessment and Evaluation of Predictions, edited by M-L Lee, M. Gail, R. Pfeiffer , G. Satten, T. Cai and A. Gandy, Springer (2013).
  • 12) V. Viallon, B. Laumon. Fraction of road traffic deaths due to speed: evolution over the 2001-2010 period in France. Accident Analysis and Prevention; 52:250-256 (2013).
  • 11) V. Viallon, E. Ecosse, M. Mesbah, J. Pouchot, J. Coste. Using extended Rasch models to assess validity of diagnostic tests in the presence of a reference standard. Journal of Applied Measurements; 13(4):376-393 (2012).
  • 10) L. El Ghaoui, V. Viallon, T. Rabbani. Safe feature elimination in sparse supervised learning. Pac. J. Optim., 8(4) : 667-698 (2012).
  • 9) V. Viallon, A. Latouche. Discrimination measures for survival outcomes: connection between AUC and the predictiveness curve. Biometrical Journal, 53(2): 217-236 (2011).
  • 8) V. Viallon, S. Ragusa, F. Clavel-Chapelon, J. Bénichou. How to evaluate the calibration of a disease risk prediction tool. Statistics in Medicine, 28(6) :901-916 (2009).
  • 7) B. Maillot, V. Viallon. Uniform limit laws of the logarithm for nonparametric estimators of the regression function in presence of censored data. Mathematical Methods of Statistics, 18(2) : 159-184 (2009).
  • 6) M. Debbarh, V. Viallon. Testing additivity in nonparametric regression under random censorship. Stat. and Prob. Letters, 78(16) : 2584-2591 (2008).
  • 5) M. Debbarh, V. Viallon. Uniform limit laws of the logarithm for the additive regression function in presence of censored data. Electronic Journal of Statistics, 2 : 516-541 (2008).
  • 4) V. Viallon. Uniform law of the logarithm for a nonparametric estimator of the regression function in the presence of censored data. C. R. Acad. Sci. Paris, Ser. I, 346(4) : 225-228 (2008).
  • 3) V. Viallon. Functional limit laws for the increments of the quantile process ; with applications, Electronic Journal of Statistics, 1 : 496-518 (2007).
  • 2) M. Debbarh, V. Viallon. Uniform convergence for estimators of the additive regression function under random censorship. C. R., Math., Acad. Sci. Paris,Ser. I, 345(2) : 97-100 (2007).
  • 1) M. Debbarh, V. Viallon. Mean square convergence for estimators of additive regression under random censorship. C. R. Acad. Sci. Paris, Ser. I, 344(3) : 205-210 (2007).

COLLABORATIONS : Biostatistique, épidémiologie et recherche clinique

  • 23) N. Assi , D.C. Thomas, M. Leitzmann, M. Stepien, V. Chajès, T. Philip, P. Vineis, C. Bamia, M.C. Boutron-Ruault , T.M. Sandanger, A. Molinuevo, H.C. Boshuizen, A. Sundkvist, T. Kuhn, R.C. Travis, K. Overvad, E. Riboli, M.J. Gunter, A. Scalbert, M. Jenab, P. Ferrari P, and V. Viallon. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case–control Study in EPIC. Cancer Epidemiology, Biomarkers and Prevention 2018, In press.
    • 22) J.L. Martin, B. Gadegbeku, D. Wu, V. Viallon, B. Laumon. Cannabis, alcohol and fatal road accidents. Plos One, 12(11)-e0187320 (2017).
  • 21) T. Lieutaud, A. N'Diaye, M. Chiron, B. Gadegbeku, V. Viallon. The decrease in Traumatic Brain Injury Epidemics Deriving from Road Traffic Collision Following Strengthened Legislative Measures in France. Plos One 11(11)-e0167082 (2016).
  • 20) K. Shield, D. Parkin, D. Whiteman, J. Rehm, V. Viallon, C. Micallef, P. Vineis, L. Rushton, F. Bray, I. Soerjomataram. Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection. Current Epidemiology Reports, 3(2):201-211 (2016).
  • 19) C. Empereur-Mot, H. Guillemain, A. Latouche, J.F. Zagury, V. Viallon, M. Montes. Predictiveness curve in virtual screening. Journal of Cheminformatics, 7(1):52 (2015).
  • 18) N. Assi, A. Fages, P. Vineis, M. Chadeau-Hyam, M. Stepien, T. Duarte-Salles, G. Byrnes, H. Boumaza, S. Knüppel, T. Kühn, D. Palli, C. Bamia, H. Boshuizen, C. Bonet, K. Overrad, M Johansson, R. Travis, M. Gunter, E. Lund, L. Dossus, B. Elena-Herrmann, E. Riboli, M. Jenab, V. Viallon, P. Ferrari. A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study. Mutagenesis, 30(6):743-53 (2015).
  • 17) N. Assi, A. Moskal, N. Slimani, V. Viallon, V. Chajes, Freisling H, Monni S, Knueppel S, Förster J, Weiderpass E, Lujan-Barroso L, Amiano P, Ardanaz E, Molina-Montes E, Salmerón D, Quirós JR, Olsen A, Tjønneland A, Dahm CC, Overvad K, Dossus L, Fournier A, Baglietto L, Fortner RT, Kaaks R, Trichopoulou A, Bamia C, Orfanos P, De Magistris MS, Masala G, Agnoli C, Ricceri F, Tumino R, Bueno de Mesquita HB, Bakker MF, Peeters PH, Skeie G, Braaten T, Winkvist A, Johansson I, Khaw KT, Wareham NJ, Key T, Travis R, Schmidt JA, Merritt MA, Riboli E, Romieu I, P. Ferrari. A Treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr., 19(2):242-254 (2015).
  • 16) A. Grasset, V. Viallon, E. Amoros, M. Hours. Typology of bicycle crashes based on a survey of a thousand of injured cyclists from a road trauma registry. Advances in Transportation Studies, 2 (Special Issue), 17-28 (2014).
  • 15) F. Stenard, O. Morales, K. Ghazal, V. Viallon, (...), F. Conti. CD49b, a major marker of regulatory T-cells type 1, predict the response to antiviral therapy of recurrent hepatitis C after liver transplantation. Biomed Res. International; 2014:290878 (2014).
  • 14) A. Hüsing, F. Canzian, L. Beckmann, M. Garcia-Closas, W.R. Diver, M.J. Thun, C.D. Berg, R.N. Hoover, R.G. Ziegler, J.D. Figueroa, C. Isaacs, A. Olsen, V. Viallon, H. Boeing, (...), R. Kaaks; on behalf of the BPC3. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. J Med Genet.;49(9):601-608 (2012).
  • 13) F. Tissier, S. Aubert, E. Leteurtre, A. Al Ghuzlan, M. Patey, M. Decaussin, L. Doucet, F. Gobet, C. Hoang, C. Mazerolles, G. Monges, K. Renaudin, N. Sturm, H. Trouette, M.C. Vacher-Lavenu, V. Viallon, E. Baudin, X. Bertagna, J. Coste, R. Libe. Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE. Am J Surg Pathol. 36(8):1194-201 (2012).
  • 12) C. Espy, W. Morelle, N. Kavian, P. Grange, C. Goulvestre, V. Viallon, C. Chereau, C. Pagnoux, J.C. Michalski, L. Guillevin, B. Weill, F. Batteux, P. Guilpain. Sialylation level of anti-proteinase 3 (PR3) antibodies determines the activity of Wegener's granulomatosis. Arthritis Rheum., 63(7):2105-15 (2011)
  • 11) J. Toubiana, E. Courtine, F. Pène, V. Viallon, P. Asfar, C. Daubin, C. Rousseau, C. Chenot, F. Ouazz, D. Grimaldi, A. Cariou, J.D. Chiche, J.P. Mira. IRAK1 variant and septic shock. Critical Care Medicine, 38(12):2287-94 (2010).
  • 10) E. Frisan, P. Pawlikowska, C. Pierre-Eugène, V. Bardet, V. Viallon, L. Gibault, O. Kosmider, S. Park, F. Kuhnowsky, M. Guesnu, P. Mayeux, C. Lacombe, F. Dreyfus, F. Porteu, M. Fontenay. p-ERK1/2 as a predictive factor of response to erythropoiesis- stimulating agents in low/int-1 myelodysplastic syndromes. Haematologica, 95(11):1964-8 (2010).
  • 9) C. Cartry, V. Viallon, P. Hornoy, C. Adamsbaum. Diffusion-weighted MR imaging of the normal fetal brain: marker of fetal brain maturation. J. Radiol., 91: 561-566 (2010).
  • 8) T. Girard, S. Mercier, V. Viallon, H. Poupet, S. Raherison, C. B_eb_ear, A. Marchal, E. Bloch, D. Vernant, B. de Barbeyrac. Etude de prévalence de l'infection à Chlamydia trachomatis et des facteurs clinico-biologiques associés dans une population d'adolescents en rupture. La Revue de Médecine Interne, 30(2): S49-S50 (2009).
  • 7) C. Chaussain-Miller, S. Opsahl-Vital, V. Viallon, L. Vermelin, M. Sixou, J.J. Lasfargues. Predictive performance of a new caries test for patients undergoing orthodontic treatment. Clinical Oral Investigations, 14(2):177-185 (2009).
  • 6) P. Fauque, P. Jouannet, C. Davy, J. Guibert, V. Viallon, S. Epelboin, J.M. Kunstmann, C. Patrat. Cumulative results including obstetrical and neonatal outcome of fresh and frozen-thawed cycles in elective single versus double fresh embryo transfers. Fertility and Sterility, 94(3): 927-35 (2009).
  • 5) P. Fauque, M. Albert, C. Serres, V. Viallon, C. Chalas, C. Davy, S. Epelboin, P. Jouannet, C. Patrat. From ultrastructural agellar sperm defects to health of babies conceived by ICSI. Reproductive BioMedicine Online, 19(3): 326-36 (2009).
  • 4) C. Patrat, I. Okamoto, P. Diabangouaya, V. Viallon, P. Le Baccon, E. Heard. Dynamic changes in paternal X-chromosome activity during imprinted X inactivation in mice. PNAS, 106(13): 5198-203 (2009).
  • 3) F. Campeotto, M. Baldassare, M.J. Butel, V. Viallon, F. Nganzali, P. Soulaines, N. Kalach, A. Lapillone, N. Laforgia, G. Moriette, C. Dupont, N. Kapel. Fecal calprotectin as a noninvasive marker of digestive distress in preterm neonates : cut-off levels. Journal of Pediatric Gastroenterology and Nutrition, 48(4): 507-10 (2009).
  • 2) C.B. d'Alva, G. Abiven-Leplace, V. Viallon, X. Bertagna, J. Bertherat. Sex steroids in androgen-secreting adrenocortical tumors : clinical and hormonal features in comparison with non tumoral causes of androgen excess. European Journal of Endocrinology, 159(5): 641-647 (2008).
  • 1) F. Pène, S. Percheron, V. Lemiale, V. Viallon, Y.E. Claessens, S. Marqué, J. Charpentier, D.C. Angus, A. Cariou, J.D. Chiche and J.P. Mira. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Critical Care Medicine, 36(3) : 690-696 (2008).